Anna Brown, Alternate Delegate representative to the AMA House of Delegates (HOD) at the American College of Radiation Oncology (ACRO), shared on X:
“Great pearls of wisdom being dropped at the NRG Oncology.
NRG 2024 session right now by Dr. Chuck Simone.
My takes:
- Immunotherapy (IO) + SBRT has potential for helping improve outcomes for early stage NSCLC pts
- The timing of IO + SBRT is important — priming -> dramatic cell kill
- Everyone should enroll patients onto the ongoing S1914 clinical trial.”
Source: Anna Brown/X
